Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Jun

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Archives of Toxicology|January 31, 2021
Development of versatile and potent monoquaternary reactivators of acetylcholinesteraseLukas Gorecki, Vendula Hepnarova, Jana Zdarova Karasova, et al.
BMC Pharmacology & Toxicology|February 23, 2018
A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesteraseKamil Kuca, Kamil Musilek, Daniel Jun, et al.
Pediatric Diabetes|August 10, 2021
Population-level management of type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population healthJohannes O Ferstad, Jacqueline J Vallon, Daniel Jun, et al.
Journal of Medicinal Chemistry|October 14, 2016
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 ActivatorsMohamed Benchekroun, Alejandro Romero, Javier Egea, et al.
Phytochemistry|November 19, 2021
Monoterpene indole alkaloids from Vinca minor L. (Apocynaceae): Identification of new structural scaffold for treatment of Alzheimer's diseaseRudolf Vrabec, Jana Maříková, Miroslav Ločárek, et al.
Bioorganic Chemistry|January 2, 2021
Alkaloids of Zephyranthes citrina (Amaryllidaceae) and their implication to Alzheimer's disease: Isolation, structural elucidation and biological activityEliška Kohelová, Jana Maříková, Jan Korábečný, et al.
International Journal of Molecular Sciences|April 30, 2021
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma CellsMonika Hudáčová, Slávka Hamuľaková, Eva Konkoľová, et al.
RSC Medicinal Chemistry|May 24, 2024
Carltonine-derived compounds for targeted butyrylcholinesterase inhibitionFilip Pidany, Jana Kroustkova, Jaroslav Jenco, et al.
European Journal of Medicinal Chemistry|August 28, 2020
The wide-spectrum antimicrobial effect of novel N-alkyl monoquaternary ammonium salts and their mixtures; the QSAR study against bacteriaOndrej Soukup, Marketa Benkova, Rafael Dolezal, et al.
Bioorganic Chemistry|April 30, 2026
Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibitionAbdullah Al Mamun, Jan Konecny, Martina Hrabinova, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Archives of Toxicology|January 31, 2021
Development of versatile and potent monoquaternary reactivators of acetylcholinesteraseLukas Gorecki, Vendula Hepnarova, Jana Zdarova Karasova, et al.
BMC Pharmacology & Toxicology|February 23, 2018
A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesteraseKamil Kuca, Kamil Musilek, Daniel Jun, et al.
Pediatric Diabetes|August 10, 2021
Population-level management of type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population healthJohannes O Ferstad, Jacqueline J Vallon, Daniel Jun, et al.
Journal of Medicinal Chemistry|October 14, 2016
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 ActivatorsMohamed Benchekroun, Alejandro Romero, Javier Egea, et al.
Phytochemistry|November 19, 2021
Monoterpene indole alkaloids from Vinca minor L. (Apocynaceae): Identification of new structural scaffold for treatment of Alzheimer's diseaseRudolf Vrabec, Jana Maříková, Miroslav Ločárek, et al.
Bioorganic Chemistry|January 2, 2021
Alkaloids of Zephyranthes citrina (Amaryllidaceae) and their implication to Alzheimer's disease: Isolation, structural elucidation and biological activityEliška Kohelová, Jana Maříková, Jan Korábečný, et al.
International Journal of Molecular Sciences|April 30, 2021
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma CellsMonika Hudáčová, Slávka Hamuľaková, Eva Konkoľová, et al.
RSC Medicinal Chemistry|May 24, 2024
Carltonine-derived compounds for targeted butyrylcholinesterase inhibitionFilip Pidany, Jana Kroustkova, Jaroslav Jenco, et al.
European Journal of Medicinal Chemistry|August 28, 2020
The wide-spectrum antimicrobial effect of novel N-alkyl monoquaternary ammonium salts and their mixtures; the QSAR study against bacteriaOndrej Soukup, Marketa Benkova, Rafael Dolezal, et al.
Bioorganic Chemistry|April 30, 2026
Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibitionAbdullah Al Mamun, Jan Konecny, Martina Hrabinova, et al.
Pageof 23